Sign in Subscribe
Class action lawsuits

Molina Healthcare Sued for Potential Securities Law Violations

Strategic Insights

— 2 min read

A lawsuit has been filed against Molina Healthcare, Inc. and its senior executives, alleging potential violations of federal securities laws. The complaint, filed in the U.S. District Court for the Central District of California, asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Molina securities. The lawsuit stems from Molina's statements about its "earnings growth profile" and ability to mitigate medical costs, which were later revealed to be inaccurate.

Key Takeaways:

  • Molina Healthcare, Inc. is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs.
  • The company allegedly faced increased medical costs pressures that it could not mitigate due to increased utilization in all three of its business lines.
  • Molina revealed on July 7, 2025, that its Q2 2025 adjusted earnings were approximately $5.50 per share, below its prior expectations.
  • The company announced a 10.2% reduction in guidance for expected adjusted earnings per share to a range of $21.50 to $22.50 per share on July 7, 2025.
  • On July 23, 2025, Molina revealed that it expected its full year 2025 adjusted earnings to be no less than $19.00 per diluted share due to a "challenging medical cost trend environment."
  • The price of Molina stock fell $32.03 per share, or 16.8%, from $190.25 per share on July 23, 2025, to $158.22 per share on July 24, 2025.
  • The lawsuit seeks to represent investors who purchased Molina securities during the relevant period.

Statistics:

  • $5.50 per share: Molina's Q2 2025 adjusted earnings per share, below its prior expectations.
  • $32.03 per share: The decline in Molina stock price on July 24, 2025.
  • 16.8%: The percentage decline in Molina stock price on July 24, 2025.
  • $190.25 per share: The closing price of Molina stock on July 23, 2025.
  • $158.22 per share: The closing price of Molina stock on July 24, 2025.
  • $900 million: The value recovered by Bleichmar Fonti & Auld LLP from Tesla, Inc.'s Board of Directors in a recent notable success.
  • $420 million: The value recovered by Bleichmar Fonti & Auld LLP from Teva Pharmaceutical Ind. Ltd. in a recent notable success.

Sources:

  • "Molina Healthcare, Inc. (MOH) and Senior Executives Named as Defendants in Securities Class Action Lawsuit" (GLOBE NEWSWIRE, Oct. 26, 2025)
  • "Why Bleichmar Fonti & Auld LLP?" (Bleichmar Fonti & Auld LLP website, accessed Oct. 26, 2025)

Read more